Prostamax (20 mg vial)

Protocol Overview

Concise summary of the regimen.

Dosing & Reconstitution

The cadence is one intramuscular injection per day, every day of the week, with no scheduled off days across the course. Preclinical studies used daily IM administration for 15 to 60 days, and the 8 to 12 week standard course extends past that window. Injections go into a large muscle group and sites are rotated systematically among the deltoid, vastus lateralis, and gluteus to avoid muscle irritation or fibrosis. At 10 mg/mL every dose in the protocol is a small draw of 5 to 10 units, which is 0.05 to 0.10 mL, so for volumes under 10 units a 30 unit or 50 unit insulin syringe reads more accurately than a 100 unit barrel; one unit here is 100 mcg. No single dose in this protocol exceeds 100 units, so nothing needs to be split across two injections.

Results Timeline

Sequence described in the research record. Individual response varies.

• Weeks 1 to 2: the course opens at 500 mcg daily, which is 5 units, as the first titration step.
• Weeks 3 to 4: the daily dose steps up to 750 mcg, which is 7.5 units.
• Weeks 5 to 8: dosing reaches the 1.0 mg maintenance level, which is 10 units (0.10 mL), and holds there.
• Weeks 9 to 12: maintenance continues at 1.0 mg daily, carrying total exposure well past the 15 to 60 day range used in the preclinical prostatitis models.
• Weeks 13 to 16: an optional extension holds 1.0 mg daily for a longer 16 week plan, after which the course ends.

Reconstitution Steps

1. Draw 2.0 mL bacteriostatic water with a sterile syringe.
2. Inject slowly down the vial wall; avoid foaming.
3. Gently swirl until dissolved (do not shake).
4. Label with date and concentration; refrigerate at 2 to 8 °C, protected from light, and use within 2 weeks. At 10 mg/mL, 1 unit = 0.01 mL » 100 mcg (0.1 mg) on a U-100 insulin syringe: 500 mcg = 5 units, 750 mcg = 7.5 units, 1.0 mg = 10 units.

Storage Instructions

Proper storage preserves peptide quality.

• Lyophilized: refrigerate at 4 °C in dry, dark conditions for short-term storage, or hold at minus 20 °C for extended stability.
• Reconstituted: refrigerate at 2 to 8 °C, protected from light; use within about 2 weeks; avoid freeze-thaw.

• Allow a vial to reach room temperature before opening to reduce condensation uptake, and return it to the refrigerator promptly after each draw.
• At 2.0 mL per 20 mg vial, a full vial holds 20 doses at the 1 mg maintenance level, which is just under 3 weeks of daily dosing, so the 2 week in-use window rather than the remaining volume sets when a vial is retired.

Supplies Needed

Planning is based on an 8 to 16 week daily protocol, averaging about 0.7 mg per day through the titration phase and 1 mg per day at maintenance, which works out to roughly 4.9 to 7 mg per week.

Peptide Vials (Prostamax, 20 mg vial):

• An 8 week course is about 40 mg at the 0.7 mg per day average, which is 2 vials of the 20 mg presentation; 12 weeks is about 60 mg, or 3 vials; 16 weeks at the 1 mg per day maintenance level is about 80 mg, or 4 vials.

Insulin Syringes (U-100):

• Per week: 7 syringes, one per day, with 30 unit or 50 unit barrels preferred since every dose sits at 10 units or below.
• 8 weeks: 56 syringes. 12 weeks: 84 syringes. 16 weeks: 112 syringes.

Bacteriostatic Water (10 mL bottles):

• Each 20 mg vial takes 2.0 mL, so one 10 mL bottle of bacteriostatic water covers 5 vials, which is more than the 2 to 4 vials any length of this course requires.

Alcohol Swabs:

• Per injection: 2 swabs, one for the vial stopper and one for the site, which is 14 swabs per week.
• 8 weeks: 112 swabs (two 100 count boxes). 12 weeks: 168 swabs. 16 weeks: 224 swabs (three 100 count boxes).

Important Notes

Practical considerations for consistency and safety.

• Use new sterile syringes, or appropriate IM syringes where a longer needle is needed, and dispose of everything in a sharps container.
• Rotate injection sites among the large muscle groups, meaning the deltoid, vastus lateralis, and gluteus, to avoid muscle irritation or fibrosis.
• Inject slowly and steadily, then wait a few seconds before withdrawing the needle. Aspiration before IM injection is no longer routinely recommended for most sites.
• For volumes under 10 units, a 30 unit or 50 unit syringe gives better precision than a 100 unit barrel, which matters most at the 500 mcg and 750 mcg titration steps.
• Regulatory Note: Prostamax is not an approved drug for human therapeutic use and is supplied for research purposes only, not for human consumption. Human clinical trial data are not yet published, and the dosing presented here is extrapolated from animal models.

How This Works

Prostamax (KEDP) belongs to the class of short bioregulatory peptides studied by Khavinson and colleagues. These tetrapeptides are proposed to modulate gene expression through epigenetic mechanisms, interacting with chromatin structure and histone proteins rather than binding a conventional cell-surface receptor. In aged human lymphocytes, KEDP has been observed to cause pericentromeric chromatin decondensation, a change that may reactivate suppressed genes. Preclinical rat models of prostatitis showed that intramuscular administration of KEDP reduced inflammatory markers and helped prevent fibrotic changes in prostate tissue, which is the basis for the daily IM route used in this protocol.

Benefits & Side Effects

Observations from the published record.

• In rat prostatitis models, intramuscular KEDP administration reduced inflammation and supported tissue normalization over 15 to 60 days.
• Studies in benign prostatic hyperplasia models showed favorable effects on prostate weight and histological parameters.
• Short bioregulatory peptides of this class generally show favorable tolerability profiles in preclinical work.
• Mild injection-site reactions such as redness and tenderness are possible, as with any intramuscular administration; systematic site rotation minimizes them.
• Human clinical trial data are not yet published, so the dosing here is extrapolated from animal models and should be read as research framing rather than established practice.

Lifestyle Factors

Complementary strategies for best outcomes.

• A balanced diet rich in vegetables, healthy fats, and adequate protein supports the baseline the protocol is layered onto.
• Regular physical activity supports circulation and overall metabolic health.
• Adequate hydration, with alcohol and caffeine limited, may support urinary function.
• Sleep and stress management support immune and hormonal balance across a course this long.

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

1. Clean the vial stopper and skin with alcohol; allow to dry completely.
2. For IM injection, use a 22 to 25 gauge, 1 to 1.5 inch needle inserted at 90 degrees into a large muscle (deltoid, vastus lateralis, or gluteus).
3. Aspiration before IM injection is no longer routinely recommended for most sites.
4. Inject slowly and steadily; wait briefly before withdrawing.
5. Rotate sites systematically to avoid muscle irritation or fibrosis.

References

Source citations for further reading.

1. Experimental study of Prostamax efficiency in chronic aseptic prostatitis therapy (Modern Research in Inflammation, 2013).
2. Effects of short peptides on lymphocyte chromatin in senile subjects (Bulletin of Experimental Biology and Medicine, 2004).